TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20

Benzinga · 10/30 20:14
TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $14 to $20.